Hoerter Steven L.
Insider CIK 1533451 · CNST Director · AGIO Chief Commercial Officer · CLVS See Remarks · RXDX Director · DCPH President and CEO, Director · CCCC Director · MBX President and CEO, Director · ORIC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MBX MBX Biosciences, Inc. | A Award deriv | 2026-08-03 | 2026-08-04 | 331,000 | — | $0 | 331,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award | 2026-08-03 | 2026-08-04 | 71,000 | — | $0 | 82,938 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2026-08-03 | 2026-08-04 | 331,000 | — | $0 | 331,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award | 2026-08-03 | 2026-08-04 | 71,000 | — | $0 | 82,938 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2026-06-24 | 2026-06-26 | 62,000 | — | $0 | 62,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2026-06-04 | 2026-06-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2026-05-01 | 2026-05-04 | 74,249 | — | $0 | 74,249 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award | 2026-05-01 | 2026-05-04 | 11,938 | — | $0 | 11,938 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2025-11-22 | 2026-04-22 | 0 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2025-11-22 | 2025-11-25 | 8,000 | — | $0 | 8,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2025-11-06 | 2026-04-22 | 33,751 | — | $0 | 33,751 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2025-11-06 | 2025-11-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2025-10-17 | 2025-10-20 | 20,000 | $13.25 | $265.0K | 20,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 35,500 | — | $0 | 35,500 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 16,000 | — | $0 | 16,000 | SEC↗ |
| MBX MBX Biosciences, Inc. | A Award deriv | 2025-04-07 | 2025-04-09 | 32,000 | — | $0 | 32,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2025-01-02 | 2025-01-06 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CCCC C4 Therapeutics, Inc. | A Award deriv | 2024-11-19 | 2024-11-21 | 65,000 | — | $0 | 65,000 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2024-06-12 | 2024-06-14 | 25,600 | — | $0 | 25,600 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 415,000 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 298,100 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 395,735 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 250,000 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer deriv | 2024-06-11 | 2024-06-11 | 270,357 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | U Tender | 2024-06-11 | 2024-06-11 | 72,763 | — | $0 | 0 | SEC↗ |
| NA Deciphera Pharmaceuticals, | D To issuer | 2024-06-11 | 2024-06-11 | 286,075 | — | $0 | 72,763 | SEC↗ |
| NA Deciphera Pharmaceuticals, | A Award | 2024-06-11 | 2024-06-11 | 286,075 | — | $0 | 358,838 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2024-02-15 | 2024-02-20 | 298,100 | — | $0 | 298,100 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-12-13 | 2023-12-14 | 30,664 | $15.37 | $471.3K | 72,763 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2023-12-12 | 2023-12-14 | 62,500 | — | $0 | 103,427 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-10-30 | 2023-10-31 | 21,573 | $12.02 | $259.3K | 40,927 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2023-10-28 | 2023-10-31 | 62,500 | — | $0 | 62,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2023-06-14 | 2023-06-15 | 20,500 | — | $0 | 20,500 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-03-21 | 2023-03-23 | 7,500 | $15.57 | $116.8K | 0 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2023-02-15 | 2023-02-16 | 250,000 | — | $0 | 250,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | S Sale | 2023-02-14 | 2023-02-16 | 30,045 | $16.00 | $480.7K | 7,500 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2022-06-17 | 2022-06-17 | 50,283 | — | $0 | 50,283 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | F Tax w/h | 2022-03-21 | 2022-03-23 | 3,150 | $9.11 | $28.7K | 37,545 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2022-01-18 | 2022-01-20 | 415,000 | — | $0 | 415,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2021-12-15 | 2021-12-17 | 270,357 | — | $0 | 270,357 | SEC↗ |
| ORIC Oric Pharmaceuticals, Inc. | A Award deriv | 2021-08-13 | 2021-08-16 | 33,250 | — | $0 | 33,250 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 13,171 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 26,342 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 13,171 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 13,171 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-23 | 26,342 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2021-06-02 | 2021-06-04 | 13,171 | — | $0 | 13,171 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | F Tax w/h | 2021-03-18 | 2021-03-22 | 700 | $42.39 | $29.7K | 43,145 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | F Tax w/h | 2021-03-18 | 2021-03-22 | 2,450 | $43.19 | $105.8K | 40,695 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2021-02-16 | 2021-02-18 | 210,000 | — | $0 | 210,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2021-01-21 | 2021-01-25 | 1,078 | — | $0 | 395,735 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2021-01-21 | 2021-01-25 | 1,078 | $25.40 | $27.4K | 43,845 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2020-08-20 | 2020-08-24 | 187 | — | $0 | 396,813 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-08-20 | 2020-08-24 | 187 | $25.40 | $4.7K | 42,767 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise deriv | 2020-07-20 | 2020-07-22 | 188 | — | $0 | 397,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-07-20 | 2020-07-22 | 188 | $25.40 | $4.8K | 42,580 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2020-06-18 | 2020-06-19 | 187 | — | $0 | 397,188 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-06-18 | 2020-06-19 | 187 | $25.40 | $4.7K | 42,392 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2020-06-04 | 2020-06-08 | 13,171 | — | $0 | 13,171 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2020-05-28 | 2020-06-01 | 188 | — | $0 | 397,375 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-05-28 | 2020-06-01 | 188 | $25.40 | $4.8K | 42,205 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2020-04-21 | 2020-04-23 | 187 | — | $0 | 397,563 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-04-21 | 2020-04-23 | 187 | $25.40 | $4.7K | 42,017 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | F Tax w/h | 2020-03-19 | 2020-03-20 | 1,012 | $36.88 | $37.3K | 48,744 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | F Tax w/h | 2020-03-19 | 2020-03-20 | 2,164 | $39.22 | $84.9K | 42,350 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | F Tax w/h | 2020-03-19 | 2020-03-20 | 4,230 | $38.26 | $161.8K | 44,514 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | F Tax w/h | 2020-03-19 | 2020-03-20 | 520 | $39.98 | $20.8K | 41,830 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | F Tax w/h | 2020-03-19 | 2020-03-20 | 4,494 | $35.78 | $160.8K | 49,756 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | M Exercise | 2020-03-18 | 2020-03-20 | 2,250 | $25.40 | $57.1K | 54,250 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2020-02-18 | 2020-02-20 | 180,000 | — | $0 | 180,000 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2019-06-06 | 2019-06-10 | 13,171 | — | $0 | 13,171 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2019-03-18 | 2020-03-20 | 2,250 | — | $0 | 397,750 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2019-03-18 | 2019-03-20 | 400,000 | — | $0 | 400,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2019-03-18 | 2019-03-20 | 22,000 | — | $0 | 22,000 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award | 2019-03-18 | 2019-03-20 | 30,000 | — | $0 | 52,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2019-03-04 | 2019-03-05 | 5,000 | — | $0 | 50,650 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2019-03-04 | 2019-03-05 | 5,000 | $39.76 | $198.8K | 15,941 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2019-03-04 | 2019-03-05 | 5,000 | $68.00 | $340.0K | 10,941 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2019-03-01 | 2019-03-05 | 5,000 | — | $0 | 55,650 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2019-03-01 | 2019-03-05 | 5,000 | $66.01 | $330.1K | 10,941 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2019-03-01 | 2019-03-05 | 5,000 | $39.76 | $198.8K | 15,941 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | F Tax w/h | 2019-02-19 | 2019-02-20 | 1,040 | $58.03 | $60.4K | 10,941 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2019-02-16 | 2019-02-20 | 2,750 | — | $0 | 5,500 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2019-02-16 | 2019-02-20 | 2,750 | — | $0 | 11,981 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | F Tax w/h | 2019-01-22 | 2019-01-23 | 5,769 | $52.82 | $304.7K | 9,231 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2019-01-20 | 2019-01-23 | 15,000 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2019-01-20 | 2019-01-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2018-09-04 | 2018-09-05 | 26,342 | — | $0 | 26,342 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2018-08-24 | 2018-08-28 | 2,050 | — | $0 | 60,650 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-08-24 | 2018-08-28 | 2,050 | $74.92 | $153.6K | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2018-08-24 | 2018-08-28 | 2,050 | $39.76 | $81.5K | 2,050 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2018-07-25 | 2018-07-27 | 2,050 | — | $0 | 62,700 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-07-25 | 2018-07-27 | 2,050 | $84.58 | $173.4K | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2018-07-25 | 2018-07-27 | 2,050 | $39.76 | $81.5K | 2,050 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-07-20 | 2018-07-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2018-06-22 | 2018-06-26 | 2,050 | — | $0 | 64,750 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-06-22 | 2018-06-26 | 2,050 | $97.58 | $200.0K | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2018-06-22 | 2018-06-26 | 2,050 | $39.76 | $81.5K | 2,050 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2018-05-23 | 2018-05-29 | 2,050 | — | $0 | 66,800 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-05-23 | 2018-05-29 | 2,050 | $85.76 | $175.8K | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2018-05-23 | 2018-05-29 | 2,050 | $39.76 | $81.5K | 2,050 | SEC↗ |
| DCPH Deciphera Pharmaceuticals, | A Award deriv | 2018-05-17 | 2018-05-21 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2018-04-23 | 2018-04-25 | 2,050 | — | $0 | 68,850 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2018-04-23 | 2018-04-25 | 2,050 | $39.76 | $81.5K | 2,050 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-04-23 | 2018-04-25 | 2,050 | $85.95 | $176.2K | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2018-03-22 | 2018-03-26 | 2,050 | — | $0 | 70,900 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-03-22 | 2018-03-26 | 2,050 | $84.65 | $173.5K | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2018-03-22 | 2018-03-26 | 2,050 | $39.76 | $81.5K | 2,050 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2018-02-22 | 2018-02-26 | 2,050 | — | $0 | 72,950 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-02-22 | 2018-02-26 | 2,050 | $78.63 | $161.2K | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2018-02-22 | 2018-02-26 | 2,050 | $39.76 | $81.5K | 2,050 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-02-16 | 2018-02-20 | 8,250 | — | $0 | 8,250 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-02-16 | 2018-02-20 | 33,000 | — | $0 | 33,000 | SEC↗ |
| RXDX Ignyta, Inc. | D To issuer deriv | 2018-02-08 | 2018-02-12 | 24,000 | — | $0 | 0 | SEC↗ |
| RXDX Ignyta, Inc. | D To issuer deriv | 2018-02-08 | 2018-02-12 | 11,666 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2018-01-23 | 2018-01-25 | 25,000 | — | $0 | 75,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2018-01-23 | 2018-01-25 | 25,000 | — | $0 | 75,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2018-01-23 | 2018-01-25 | 25,000 | $39.76 | $994.0K | 25,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-01-23 | 2018-01-25 | 25,000 | $74.83 | $1.87M | 0 | SEC↗ |
| RXDX Ignyta, Inc. | A Award deriv | 2017-06-13 | 2017-06-19 | 11,666 | — | $0 | 11,666 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2017-02-21 | 2017-02-23 | 47,600 | — | $0 | 47,600 | SEC↗ |
| RXDX Ignyta, Inc. | A Award deriv | 2016-12-08 | 2016-12-09 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2016-02-16 | 2016-02-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2015-03-05 | 2015-03-09 | 20,000 | — | $0 | 26,206 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2015-03-05 | 2015-03-09 | 20,000 | $11.02 | $220.4K | 20,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-03-05 | 2015-03-09 | 20,000 | $80.00 | $1.60M | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2015-03-02 | 2015-03-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2015-02-17 | 2015-02-19 | 10,000 | — | $0 | 46,206 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2015-02-17 | 2015-02-19 | 10,000 | $11.02 | $110.2K | 10,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-02-17 | 2015-02-19 | 10,000 | $72.00 | $720.0K | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2015-01-16 | 2015-01-20 | 10,000 | — | $0 | 56,206 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2015-01-16 | 2015-01-20 | 10,000 | $11.02 | $110.2K | 10,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-01-16 | 2015-01-20 | 10,000 | $67.00 | $670.0K | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2015-01-13 | 2015-01-15 | 10,000 | — | $0 | 66,206 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2015-01-13 | 2015-01-15 | 10,000 | $11.02 | $110.2K | 10,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-01-13 | 2015-01-15 | 10,000 | $62.00 | $620.0K | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2014-01-10 | 2014-01-14 | 65,000 | — | $0 | 65,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise deriv | 2013-06-04 | 2013-06-06 | 10,000 | — | $0 | 76,206 | SEC↗ |
| CLVS Clovis Oncology, Inc. | M Exercise | 2013-06-04 | 2013-06-06 | 10,000 | $11.02 | $110.2K | 10,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-06-04 | 2013-06-06 | 10,000 | $73.06 | $730.6K | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2013-03-01 | 2013-03-04 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2012-03-01 | 2012-03-05 | 60,000 | — | $0 | 60,000 | SEC↗ |